probuphine Drug Patent Profile

✉ Email this page to a colleague

When do Probuphine patents expire, and what generic alternatives are available?

Probuphine is a drug marketed by Reacx Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has sixteen patent family members in thirteen countries.

The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Probuphine

A generic version of probuphine was approved as buprenorphine hydrochloride by HOSPIRA on June 3^rd, 1996.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for probuphine?
What are the global sales for probuphine?
What is Average Wholesale Price for probuphine?

Summary for probuphine

International Patents:	16
US Patents:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	19
Clinical Trials:	8
Patent Applications:	4,122
Drug Prices:	Drug price information for probuphine
What excipients (inactive ingredients) are in probuphine?	probuphine excipients list
DailyMed Link:	probuphine at DailyMed

Drug patent expirations by year for probuphine

Recent Clinical Trials for probuphine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	Phase 2
Braeburn Pharmaceuticals	Phase 3
National Institute on Drug Abuse (NIDA)	Phase 3

See all probuphine clinical trials

US Patents and Regulatory Information for probuphine

probuphine is protected by one US patents.

Patents protecting probuphine

Implantable polymeric device for sustained release of buprenorphine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: FOR OPIOID DEPENDENCE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Reacx Pharms	PROBUPHINE	buprenorphine hydrochloride	IMPLANT;IMPLANTATION	204442-001	May 26, 2016		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for probuphine

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Reacx Pharms	PROBUPHINE	buprenorphine hydrochloride	IMPLANT;IMPLANTATION	204442-001	May 26, 2016	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for probuphine

See the table below for patents covering probuphine around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	03101358		⤷ Sign Up
New Zealand	536965	Nonerodible polymeric matrix with buprenorphine encapsulated for the treatment of opiate addiction and pain	⤷ Sign Up
Portugal	2561860		⤷ Sign Up
Japan	4668611		⤷ Sign Up
European Patent Office	1509182	DISPOSITIF POLYMERE IMPLANTABLE PERMETTANT LA LIBERATION PROLONGEE DE BUPRENORPHINE (IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE)	⤷ Sign Up
Cyprus	1120510		⤷ Sign Up
Slovenia	2561860		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for probuphine

Recent Clinical Trials for probuphine

Patents protecting probuphine

Make Better Decisions: Try a trial or see plans & pricing